Perkins Capital Management reduces stake in St. Jude Medical by 4.7% — 5 takeaways

During the most recent quarter, Perkins Capital Management lowered its stake in St. Jude Medical by 4.71 percent, according to The Market Digest.

Advertisement

Here are five takeaways:

 

1. Presently, the firm holds 85,938 St. June Medical shares for a total value of nearly $5.21 million.

 

2. St. Jude Medical comprises 6.21 percent of Perkins Capital Management’s portfolio.

 

3. St. Jude Medical had earnings per share reaching $0.90 for the quarter.

 

4. The company had revenue hitting nearly $1.45 billion for the quarter.

 

5. St. Jude Medical develops, manufactures and distributes cardiovascular medical devices to manage chronic pain and movement disorders.

 

More device news:
Novel technologies make a splash in outpatient spine setting — Dr. Nick Shamie weighs in
Integra LifeSciences Holdings shares up .17%: 4 points
FDA panel finds Cartiva SCI safe, effective: 3 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • SurGenTec’s ION-C earned FDA 510(k) clearance for ION-C navigation instruments with the ION-C posterior cervical facet fixation implant, according to…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.